To include your compound in the COVID-19 Resource Center, submit it here.

Acorda jumps on Ampyra patent speculation

Acorda Therapeutics Inc. (NASDAQ:ACOR) jumped $5.71 (27%) to $27.13 before trading was halted on Thursday following

Read the full 163 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE